Literature DB >> 16195631

Selective down-regulation of extracellular matrix gene expression by bone marrow derived stem cell transplantation into infarcted myocardium.

Xiaohua Xu1, Zenglu Xu, Yuanyuan Xu, Guanghui Cui.   

Abstract

BACKGROUND: Myocardial fibrosis is a major component of ventricular remodeling after myocardial infarction (MI). The aim of the present study was to determine the outcome of transplantation into ischemic myocardium of bone marrow derived stem cell (MSC) on left ventricular (LV) function and remodeling, and to look closely at extracellular matrix gene expression. METHODS AND
RESULTS: MI was induced by direct ligation of the left anterior descending coronary artery in rats, followed by MSC transplantation into the ischemic myocardium. Hemodynamic evaluations were performed at 7 and 28 days after coronary ligation. Changes in the mRNA expressions of collagen type I and type III, matrix metalloproteinase-1, tissue inhibitor of matrix metalloproteinase (TIMP)-1 and transforming growth factor (TGF)-beta(1) were investigated using reverse transcription polymerase chain reaction and in situ hybridization after MI. Heart/body weight ratio in the MI + MSC group decreased after coronary ligation. However, LV systolic pressure and LV peak velocities of contraction and relaxation significantly increased compared with the MI group (p<0.01). There was marked up-regulation of the mRNA expressions of collagen types I and III, TIMP-1 and TGF-beta(1) in the MI rats, all of which were significantly attenuated by MSC transplantation.
CONCLUSIONS: MSC transplantation could inhibit LV remodeling, improve heart function and reduce the expression of extracellular matrix genes.

Entities:  

Mesh:

Year:  2005        PMID: 16195631     DOI: 10.1253/circj.69.1275

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Growth factors enhance liver regeneration in acute-on-chronic liver failure.

Authors:  Chandan Kumar Kedarisetty; Lovkesh Anand; Arshi Khanam; Anupam Kumar; Archana Rastogi; Rakhi Maiwall; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-05-25       Impact factor: 6.047

Review 2.  Stem cell recruitment after injury: lessons for regenerative medicine.

Authors:  Robert C Rennert; Michael Sorkin; Ravi K Garg; Geoffrey C Gurtner
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

3.  Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction.

Authors:  Jun Guo; Guo-sheng Lin; Cui-yu Bao; Zhi-min Hu; Ming-yan Hu
Journal:  Inflammation       Date:  2007-05-12       Impact factor: 4.092

Review 4.  Stem cells as a potential future treatment of pediatric intestinal disorders.

Authors:  Troy A Markel; Paul R Crisostomo; Tim Lahm; Nathan M Novotny; Frederick J Rescorla; Joseph Tector; Daniel R Meldrum
Journal:  J Pediatr Surg       Date:  2008-11       Impact factor: 2.545

5.  Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond.

Authors:  S Van Linthout; Ch Stamm; H-P Schultheiss; C Tschöpe
Journal:  Cardiol Res Pract       Date:  2011-03-06       Impact factor: 1.866

6.  PROTECTIVE EFFECT OF Ailanthus excelsa ROXB IN MYOCARDIAL INFARCTION POST MESENCHYMAL STEM CELL TRANSPLANTATION: STUDY IN CHRONIC ISCHEMIC RAT MODEL.

Authors:  Xia Gong
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29

Review 7.  Current stem cell delivery methods for myocardial repair.

Authors:  Calvin C Sheng; Li Zhou; Jijun Hao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.